MedTrace Logo

Velphoro and Impact on the Oral Cavity and Gut Microbiome

NCT03409757 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 22

Last updated 2020-11-25

No results posted yet for this study

Summary

This pilot study will be carried out to determine if the regular intake of iron-based Velphoro® by hyperphosphatemia patients influences the microbiome in the oral cavity and/or the gut.

Conditions

  • Hyperphosphatemia

Interventions

DRUG

Velphoro

4 weeks

OTHER

saliva collection

2 samples

OTHER

Supragingival biofilm collection

2 samples

OTHER

stool collection

2 samples

OTHER

blood collection

2 samples

Sponsors & Collaborators

  • RWTH Aachen University

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2018-02-28
Primary Completion
2020-10-06
Completion
2020-10-06

Countries

  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03409757 on ClinicalTrials.gov